Publications
5491 Results
- Journal / Conference
- International Journal of Cancer Jan 1;148(1):99-105. Epub 2020 Sep 24.Sep 15. doi: 10.1002/ijc.33282. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Cancer Control and Prevention and Epidemiology
- PMID
- PMID32930425
- PMC
- PMC8135907
- Study Number(s)
- S0000, SWOG-9217
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
- Journal / Conference
- Journal of the National Cancer Institute Mar 1;113(3):244-257. doi: 10.1093/jnci/djaa155.
- Year
- 2021
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID33022716
- PMC
- PMC7936064
When offered to participate: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials
- Journal / Conference
- INTERNATIONAL SYMPOSIUM ON CHILDHOOD, ADOLESCENT AND YOUNG ADULT HODGKIN LYMPHOMA (ISCAYAHL) (5/13-16/20, Berlin, Germany)
- Year
- 2021
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S1826
An Intergroup Approach for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Adolescents and Young Adults (AYA): SWOG S1826
- Journal / Conference
- Clinical Cancer Research Jan 1;27(1):267-275
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID32958699
- PMC
- PMC7785628
- Study Number(s)
- CTSU/C80405
Genomic analysis of germline variation associated with survival of colorectal cancer patients treated with chemotherapy plus biologics in CALGB/SWOG 80405 (Alliance)
- Journal / Conference
- Clinical Lung Cancer May;22(3):170-177. doi: 10.1016/j.cllc.2020.09.013. Epub 2020 Oct 14.
- Year
- 2021
- Research Committee(s)
- Lung
- PMID
- PMID33221175
- PMC
- PMC8044254
- Study Number(s)
- S1400K
A Phase II Study of Telisotuzumab Vedotin (Teliso-V, Abbv-399) in Patients with C-Met Positive Stage I or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-Study SWOG S1400K, NCT03574753)
- Journal / Conference
- Clinical Lung Cancer May;22(3):178-186. doi: 10.1016/j.cllc.2020.10.015. Epub 2020 Nov 10.
- Year
- 2021
- Research Committee(s)
- Lung
- PMID
- PMID33358401
- Study Number(s)
- S1400A
SWOG S1400A (NCT #02154490): A phase II study of Durvalumab for previously treated patients with stage IV squamous cell lung cancer (Lung-MAP sub-study)
- Journal / Conference
- Journal of Clinical Oncology Feb 1;39(4):285-294
- Year
- 2021
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID33356422
- PMC
- PMC8462593
- Study Number(s)
- S1406
Randomized trial of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (SWOG S1406)
- Journal / Conference
- Lancet Haematology Jan;8(1):e45-e54. doi: 10.1016/S2352-3026(20)30354-9. Epub 2020 Dec 22
- Year
- 2021
- Research Committee(s)
- Myeloma
- PMID
- PMID33357482
- Study Number(s)
- S1211
Bortezomib, Lenalidomide, Dexamethasone with or without Elotuzumab for Untreated, High-Risk Myeloma – Primary Analysis of the SWOG-1211 Randomized Phase II Trial
- Journal / Conference
- Nature Genetics, Jan;53(1):65-75
- Year
- 2021
- Research Committee(s)
- Cancer Control and Prevention and Epidemiology
- PMID
- PMID33398198
- PMC
- PMC8148035
- Study Number(s)
- S0000, SWOG-9217
Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction
- Journal / Conference
- JAMA Oncology 2021 Feb 1;7(2):246-254. doi: 10.1001/jamaoncol.2020.6353; Dec 17;e206353. doi: 10.1001/jamaoncol.2020.6353. Online ahead of print
- Year
- 2021
- Research Committee(s)
- Symptom Control and Quality of Life
- PMID
- PMID33331905
- PMC
- PMC7747039
- Study Number(s)
- S0702